Tata lmg expands growing enterprise business

Diagnostics and online pharmacy platform Tata lmg is doubling down on its business-to-business (B2B) offerings, which bolstered growth in FY25, a top executive told Mint.

- Sowmya Ramasubramanian

The enterprise business accounts for 30% of the company’s revenue and is expected to grow substantially by the end ofthe current fiscal year, Gaurav Agarwal, co-founder of Tata lmg, said in an interview. “Our enterprise business is growing very fast—almost 100% year on year. We see tremendous growth opportunities in corporate programmes, especially in diagnostics.” Tata lmg’s B2B segment includes the sale of selling healthcare plans to its corporate clientele. The company has been expanding its diagnostics lab centres and increasing the availability of its services beyond metro cities as it prepares to raise external capital of $300 million. Agarwal declined to comme